COST ANALYSIS OF THERAPY IN BREAST CANCER PATIENTS UNDERGOING CHEMOTHERAPY WHICH HOSPITAL IN DR. Sardjito IN 2012
ABSTRACT: Breast cancer is a malignant tumor in the breast tissue, and is a type of cancer that suffered by many women in Indonesia and the world. In addition to causing undesirable effects, these diseases also cause a great economic loss. One of the therapies for breast cancer is chemotherapy. The purpose of this research is to estimate the total of direct medical costs on patients with breast cancer who received chemotherapy, large of cost components required, and the factors that affect the amount of the cost. Research is done by the descriptive non-experimental design, with the technique of collecting data in a retrospective from the medical record and payment data of patients. The subject of this research is the patient with breast cancer who get chemotherapy, undergo hospitalization in RSUP Dr. Sardjito Yogyakarta during 2012, and in accordance with the criteria of inclusion and exclusion of research. The analysis is performed by calculating all the cost associated with inpatient care to treat the condition of breast cancer and chemotherapy spent by the patients, based on cost perspective of the hospital. Cost data is then analyzed to obtain a description of total cost and cost component that needs to be spent, and to analyze the factors that affect the amount of the total cost by Kruskall-Wallis and Mann-Whitney statistical test. Based on the result of the research, there are 201 case with 69 patient who meet the criteria of inclusion of the subject of the research. The average of total cost of patients per chemotherapy cycle on this research is Rp 5.670.996,92 ± 5.866.675,99. Cost components of the total cost is the cost of drugs and medical goods, medical action costs, the cost of supporting diagnostics, the cost of visite, cost of nursing, accommodation costs, the cost of ICU and ICCU, cost of Emergency Room, cost of IP2S/CSSD, cost of blood transfusion, cost of the oxygen service, cost of nutritionist, administration cost, and other cost. Components of the cost of medicines and medical goods had the largest percentage of the average total cost of therapy (69.30%). Factors that affect the amount of total cost are the age of the patients (p = 0,003), breast cancer stage (p = 0,000), chemotherapy regimen (p = 0,000), the presence of another disease (p = 0,000), length of stay in hospital (p = 0,000), room class of hospitalized patients (p = 0,000), and the payment line of the patients (p = 0,000).
